CUA: RCC Genetic Screening (2013): Difference between revisions

From UrologySchool.com
Jump to navigation Jump to search
Created page with "'''See [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854468/ Original Guideline]''' '''*****All information below contained in more inclusive Kidney Cancer Chapter Notes''' ===== Criteria for referring patients with renal tumours for genetic assessment ===== # Patients with any renal tumour (benign or malignant) AND any one of the following: ## Bilaterality or multifocality ## Age of onset ≤45 ## 1st or 2nd degree relative with any renal tumour ## A history of pneu..."
 
No edit summary
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
'''See [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854468/ Original Guideline]'''
'''See [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854468/ Original Guideline]'''


'''*****All information below contained in more inclusive Kidney Cancer Chapter Notes'''
'''*****All information below contained in more inclusive [[Kidney Cancer: Diagnosis and Evaluation]] Chapter Notes'''


===== Criteria for referring patients with renal tumours for genetic assessment =====
===== <span style="color:#ff0000">Criteria for referring patients with renal tumours for genetic assessment</span> =====


# Patients with any renal tumour (benign or malignant) AND any one of the following:
# Patients with any renal tumour (benign or malignant) AND any one of the following:

Latest revision as of 11:28, 5 April 2022

See Original Guideline

*****All information below contained in more inclusive Kidney Cancer: Diagnosis and Evaluation Chapter Notes

Criteria for referring patients with renal tumours for genetic assessment[edit | edit source]
  1. Patients with any renal tumour (benign or malignant) AND any one of the following:
    1. Bilaterality or multifocality
    2. Age of onset ≤45
    3. 1st or 2nd degree relative with any renal tumour
    4. A history of pneumothorax* (*or 1st degree relative with same) (found in BHDS)
    5. One of the following dermatologic findings:
      1. Skin leiomyomas* (found in HLRCC)
      2. Skin fibrofolliculomas/trichodisomas* (found in BHDS)
    6. One of the following associated tumours:
      1. Pheochromocytoma/paraganglioma*
      2. Hemangioblastoma of the retina, brainstem, cerebellum or spinal cord*
      3. Early onset of multiple uterine fibroids (<30 years of age)*
      4. Lymphangiomyomatosis*
      5. Childhood seizure disorder*
  2. Patients with non-clear cell carcinoma with unusual associated features (e.g., chromophobe, oncocytic or hybrid tumours)
  3. Patients, with or without RCC, who report a family member (any) with a known clinical or genetic diagnosis of any one of the following:
    1. Von Hippel-Lindau syndrome
    2. Hereditary papillary renal cell cancer
    3. Hereditary leiomyomatosis and renal cell cancer
    4. Birt-Hogg-Dubé syndrome
    5. Hereditary paraganglioma/pheochromocytoma
    6. Tuberous sclerosis